Preview

Medical Visualization

Advanced search

Staging of Bisphosphonate-Related Osteonecrosis of the Jaws Inpatients with Malignant Tumors according multislice Computed Tomography

Abstract

Aim of the study: the development of a classification of bisphosphonate - related osteonecrosis of the jaw (BRONJ) based on the analysis of multispiral computed tomography (MSCT), carried out during the treatment of patients with BRONJ. Materials and methods. Retrospective analysis of the results of 200 patients with bisphosphonate osteonecrosis of the jaw MSCT, which were treated at the Department of oral and maxillofacial, reconstructive and plastic surgery in the period from 2009 to 2015. All patients received therapy with bisphosphonates in the context of metastatic bone lesions, the development of osteonecrosis in the majority of cases were preceded by tooth extraction, trauma by prosthesis or the presence of chronic foci of infection. The patients underwent conservative treatment with a view to stimulating the formation of a sequestrum with a local application of UV-ozone therapy, operative therapy (sequestrectomy) performed in the presence of a sequestrum. MSCT was performed 1 time per 6 months, to determine the dynamics of treatment. Results. A new classification of BRONJ: the initial stage of a pathological increase in bone density, stage 1 - destructive lesion, stage 2 - formation of sequestration, stage 3 - progression of sequestration, stage 4 - reparation. Conclusion. The proposed classification is based on staging of the disease in the dynamics of its course. The proposed classification allows to assess a lesion of bisphosphonate osteonecrosis of the jaws in dynamics, as a basis for selection of appropriate treatment - conservative or surgical (definition of sequestrectomy).

About the Author

Natalia Aleksandrovna Zhukova
A.I. Evdokimov Moscow state university of medicine and dentistry
Russian Federation


References

1. Заславская Н.А. (Жукова Н.А.), Дробышев А.Ю., Лежнев Д.А. Диагностика и лечение остеонерозов челюстей у больных злокачественными новообразованиями, получающих терапию антирезорбтивными препаратами (бисфосфонаты, деносумаб). Вестник МВД. 2014; 1: 14-16.

2. Заславская Н.А. (Жукова Н.А.) Оптимизация профилактики и лечения бисфосонатных остеонекрозов челюстей у больных со злокачественными новообразованиями: Дис.. канд. мед. наук. М., 2014. 166 c.

3. Kumar V., Shahi A.K. Nitrogen containing bisphosphonates associated osteonecrosis of the jaws: A review for past 10 year literature. Dent. Res. J. (Isfahan). 2014; 11: 147-153.

4. Khan A.A., Morrison A., Hanley D.A. et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015; 30: 3-23.

5. Манзюк Л.В., Османова Л.И., Снеговой А.В. Зомета в лечении костных метастазов и нарушений минерального обмена у онкологических больных. Русский медицинский журнал. Онкология. 2007; 25: 1924-1933.

6. Заславская Н.А. (Жукова Н.А.), Дробышев А.Ю., Волков А.В. Опыт лечения остеонекрозов челюстей у пациентов, получающих антирезорбтивную терапию (бисфосфонаты, “Деносумаб”). Cathedra. 2014; 47: 32-34.

7. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J. Oral. Max. Surg. 2003; 61: 1115-1117.

8. Ruggiero S.L., Fantasia J., Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelienes for diagnosis, staging and management. Oral. Gurg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 2006; 102: 433-441.

9. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. J. Oral. Maxillofac. Surg. 2007; 65: 369-376.

10. Ruggiero S.L., Dodson T.B., Assael L.A. et al. B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws - 2009 Update. J. Oral. Maxillofac. Surg. 2009; 67: 2-12.

11. McMahon R.E., Bouquot J.E., Glueck C.J. et al. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease. J. Oral. Maxillofac. Surg. 2007; 65:1899-1900.

12. Mawardi H., Treister N., Richardson P. et al. Sinus tracts - an early sign of bisphosphonate-related osteonecrosis of the jaws? J. Oral. Maxillofac. Surg. 2009; 67: 593-601.

13. Bagan J.V., Jimenez Y., Diaz J.M. et al. Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification. Oral. Oncol. 2009; 45:645-646.

14. Bedogni A., Fusco V., Agrillo A., Campisi G. Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaws (BRONJ). Oral. Dis. 2012; 18: 621-623.

15. Ruggiero S.L., Dodson T.B, Fantasia J. et al. American Association of Oral and Maxillofacial Surgeons Position Paper on medical-related osteonecrosis of the jaw - 2014 update. J. Oral. Maxillofac. Surg. 2014; 72: 1938-1956.


Review

For citations:


Zhukova N.A. Staging of Bisphosphonate-Related Osteonecrosis of the Jaws Inpatients with Malignant Tumors according multislice Computed Tomography. Medical Visualization. 2016;(3):17-27. (In Russ.)

Views: 1356


ISSN 1607-0763 (Print)
ISSN 2408-9516 (Online)